Authors:
TUBIANAMATHIEU N
LEJEUNE C
BONNIER P
GENET D
CLAVERE P
BERDAH JF
DELABY F
ADJADJ D
ROULLET B
MURACCIOLE X
RHEIN B
JUIN P
PIANA L
Citation: N. Tubianamathieu et al., INFLAMMATORY BREAST-CANCER - CHEMOTHERAPY AND CONCOMMITTANT RADIOTHERAPY, European journal of cancer, 34, 1998, pp. 66-66
Citation: C. Lejeune, INSTABILITY HAS A PERINATAL IMPACT ON PRE GNANT-WOMEN - PEDIATRICIANSCAN AND MUST ACT, Archives de pediatrie, 5(3), 1998, pp. 251-254
Citation: P. Arveux et al., WHAT ARE THE COSTS OF AN EFFICIENT SCREEN ING STRATEGY FOR COLONIC-CANCER, Gastroenterologie clinique et biologique, 22(3BIS), 1998, pp. 49-55
Authors:
TUBIANAMATHIEU N
BONNIER P
DELABY F
MURRACIOLE X
LEJEUNE C
HADJADJ DJ
JUIN P
PIANA L
Citation: N. Tubianamathieu et al., TREATMENT OF CARCINOMA OF THE UTERINE CERVIX WITH CONCOMITANT CISPLATIN, 5-FLUOROURACIL AND SPLIT COURSE HYPERFRACTIONATED RADIOTHERAPY, European journal of obstetrics, gynecology, and reproductive biology, 77(1), 1998, pp. 95-100
Authors:
BONNIER P
BESSENAY F
SASCO AJ
BEEDASSY B
LEJEUNE C
ROMAIN S
CHARPIN C
PIANA L
MARTIN PM
Citation: P. Bonnier et al., IMPACT OF MENOPAUSAL HORMONE-REPLACEMENT THERAPY ON CLINICAL AND LABORATORY CHARACTERISTICS OF BREAST-CANCER, International journal of cancer, 79(3), 1998, pp. 278-282
Citation: C. Lejeune et A. Lonvaudfunel, SEQUENCE OF DNA 16S 23S SPACER REGION OF LEUCONOSTOC-OENOS (OENOCOCCUS OENI) - APPLICATION TO STRAIN DIFFERENTIATION/, Research in microbiology, 148(1), 1997, pp. 79-86
Authors:
LACCOURREYE O
KUGELSTADT P
HUGUES FC
BRIERE J
LEJEUNE C
BRASNU D
Citation: O. Laccourreye et al., INTRAPAROTID SUBACUTE NECROTIZING HISTIOCYTIC LYMPHADENITIS (KIKUCHI-FUJIMOTOS DISEASE), Journal of otolaryngology, 26(1), 1997, pp. 64-66
Authors:
DESCHILDRE A
CROQUETTE MF
FERRARO F
VIGNERON P
DELOBEL B
LEJEUNE C
DOREMUS B
LECLERC F
Citation: A. Deschildre et al., CONTRIBUTION OF KARYOTYPE IN THE DIAGNOSI S OF IMMUNE-DEFICIENCY - REPORT OF A CASE OF IMMUNE-DEFICIENCY ASSOCIATED WITH CHROMOSOMAL INSTABILITY, Revue francaise d'allergologie et d'immunologie clinique, 37(2), 1997, pp. 137-142
Authors:
BONNIER P
ROMAIN S
DILHUYDY JM
BONICHON F
JULIEN JP
CHARPIN C
LEJEUNE C
MARTIN PM
PIANA L
Citation: P. Bonnier et al., INFLUENCE OF PREGNANCY ON THE OUTCOME OF BREAST-CANCER - A CASE-CONTROL STUDY, International journal of cancer, 72(5), 1997, pp. 720-727
Authors:
KRAMP RA
CARON N
GENARD J
LEJEUNE C
GULBIS E
HERMAN A
Citation: Ra. Kramp et al., DIFFERENTIAL-EFFECTS OF SULINDAC ON RENAL HEMODYNAMICS AND FUNCTION IN THE RAT, European journal of pharmacology, 330(2-3), 1997, pp. 165-176
Citation: C. Lejeune, DECLINING NUMBER OF FOREIGN PEDIATRICIANS AND PEDIATRIC HOSPITAL-CAREIN ILE-DE-FRANCE, Archives de pediatrie, 3(12), 1996, pp. 1283-1284
Authors:
LHOMME C
KERBRAT P
LEJEUNE C
GUASTALLA JP
FUMOLEAU P
GOUPIL A
HERON JF
CASSIN MA
PRUVOT I
SOARES JA
CHAZARD M
Citation: C. Lhomme et al., CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY, Seminars in oncology, 23(5), 1996, pp. 48-54
Authors:
LEJEUNE C
TATON M
COLLYN L
ROCMANS P
DUMONT JE
MOCKEL J
Citation: C. Lejeune et al., REGULATION AND METABOLIC ROLE OF PHOSPHOLIPASE-D ACTIVITY IN HUMAN THYROID AND CULTURED DOG THYROCYTES, The Journal of clinical endocrinology and metabolism, 81(10), 1996, pp. 3526-3534
Authors:
BONNETERRE J
TUBIANAHULIN M
CHOLLET P
CHEVALLIER B
FUMOLEAU P
KERBRAT P
VIE B
KHAYAT D
TUBIANA N
LEJEUNE C
LEGRAND A
SOARES JA
PELLAECOSSET B
Citation: J. Bonneterre et al., TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT G-CSF ASA FIRST LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)/, European journal of cancer, 31A, 1995, pp. 354-354
Authors:
BRUHWYLER J
LIEGEOIS JF
LEJEUNE C
ROGISTER F
DELARGE J
GECZY J
Citation: J. Bruhwyler et al., NEW DIBENZAZEPINE DERIVATIVES WITH DISINHIBITORY AND OR ANTIDEPRESSANT POTENTIAL - NEUROCHEMICAL AND BEHAVIORAL-STUDY IN THE OPEN-FIELD ANDFORCED SWIMMING TESTS/, Behavioural pharmacology, 6(8), 1995, pp. 830-838
Authors:
NIOLOUX C
FLOCHTUDAL C
JABYSERGENT MP
LEJEUNE C
Citation: C. Nioloux et al., METHEMOGLOBINEMIA ASSOCIATED WITH LIDOCAI NE-PRILOCAINE CREAM (EMLA) IN A PREMATURE-INFANT, Archives de pediatrie, 2(3), 1995, pp. 291-292
Authors:
LEJEUNE C
LONVAUDFUNEL A
TENBRINK B
HOFSTRA H
VANDERVOSSEN JMBM
Citation: C. Lejeune et al., DEVELOPMENT OF A DETECTION SYSTEM FOR HISTIDINE DECARBOXYLATING LACTIC-ACID BACTERIA BASED ON DNA PROBES, PCR AND ACTIVITY TEST, Journal of Applied Bacteriology, 78(3), 1995, pp. 316-326
Authors:
BONNIER P
CHARPIN C
LEJEUNE C
ROMAIN S
TUBIANA N
BEEDASSY B
MARTIN PM
SERMENT H
PIANA L
Citation: P. Bonnier et al., INFLAMMATORY CARCINOMAS OF THE BREAST - A CLINICAL, PATHOLOGICAL, OR A CLINICAL AND PATHOLOGICAL DEFINITION, International journal of cancer, 62(4), 1995, pp. 382-385
Authors:
BONNIER P
ROMAIN S
CHARPIN C
LEJEUNE C
TUBIANA N
MARTIN PM
PIANA L
Citation: P. Bonnier et al., AGE AS A PROGNOSTIC FACTOR IN BREAST-CANCER - RELATIONSHIP TO PATHOLOGICAL AND BIOLOGIC FEATURES, International journal of cancer, 62(2), 1995, pp. 138-144
Authors:
ROSSI JF
BOUABDALLAH R
FUZIBET JG
LEPEU G
MARTIN C
GRIS JC
MARIT G
KUGEL C
CAPDEVILA V
TUBIANA N
LEJEUNE C
BATAILLE R
SOTTO JJ
Citation: Jf. Rossi et al., RESULT OF RANDOMIZED STUDY COMPARING MELPHALAN-PREDNISONE (MP) TO ALTERNATING MP AND HYDROXYUREA-VAD (VINCRISTINE, ADRIAMYCIN, DEXAMETHASONE, HVAD) IN 148 PATIENTS WITH MULTIPLE-MYELOMA (MM), Blood, 86(10), 1995, pp. 735-735
Authors:
ROUZIOUX C
COSTAGLIOLA D
BURGARD M
BLANCHE S
MAYAUX MJ
GRISCELLI C
VALLERON AJ
ALLEMON MC
ARMENGAUD D
BABINET JM
BALDE P
BENFADEL F
BENSADOUN R
BERTEROTIERE D
BODDAERT M
BOMPARD Y
BOTTO C
BRUNNER AM
CACAULT JA
CARLUSMONCOMBLE C
CIRARUVIGNERON N
COHEN C
COLINGORKI AM
COURPOTIN C
CRUMIERE C
DALLOT MC
DANDINE M
DECREPY A
DEBONS M
DEBRE M
DENAVIT MF
DEVIDAS A
DUMONTEL M
FIRTION G
FLOCH C
FRANCOUAL C
FURIOLI J
GANTZER A
GRANIER F
GUILLOT F
HELLER B
HURAUXRENDU C
LABRUNE P
LACHASSINE E
LACROIX A
LANZA M
LAJALLE H
LELORIER B
LEBLANC A
LEBRUN F
LEJEUNE C
MAMOU J
MAY A
MAZI F
MEYER A
MOUCHNINO G
NARCY P
NOSEDA G
PASCAL C
PAUTARD B
ROBIN M
RONZIER M
ROPERT JL
ROUSSET MC
SAILLANT A
SCART G
SEAUME H
SEGUY D
TALON P
TARDIEU M
TERRIS J
VALDES L
VEBER F
VEDRENNE J
VIAL M
VINAS A
VINCENT N
WIPFF P
Citation: C. Rouzioux et al., ESTIMATED TIMING OF MOTHER-TO-CHILD HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TRANSMISSION BY USE OF A MARKOV MODEL, American journal of epidemiology, 142(12), 1995, pp. 1330-1337